Generalised Anxiety Disorder: Persistent Anxiety Beyond Immediate Threat

Generalised anxiety disorder is more than occasional worry. It causes excessive, difficult to control anxiety across several areas of life for many months, together with physical tension and impaired functioning. Diagnosis requires a persistent pattern, careful exclusion of other disorders and medical causes, and treatment matched to severity and preference.

What generalised anxiety disorder is Generalised anxiety disorder, usually shortened to GAD, is a persistent anxiety disorder centred on excessive and difficult to control worry. The worry spreads across several areas of life, such as health, family, work, finances, study or everyday responsibilities. It is not limited to one immediate danger, one feared object or an occasional stressful event. GAD can affect thoughts, the body, sleep, relationships and the ability to carry out ordinary activities. Anxiety is a normal protective response Anxiety helps the brain and body prepare for possible danger, uncertainty or demanding situations. It can sharpen attention, increase energy and encourage useful preparation before an examination, interview or difficult conversation. Normal anxiety usually reduces when the situation passes or when practical action resolves the problem. The presence of anxiety alone therefore does not mean that someone has an anxiety disorder. When worry becomes a disorder Worry becomes more suggestive of GAD when it is excessive, pervasive and difficult to control. It occurs on most days, moves repeatedly between different topics and creates significant distress or functional impairment. The person may recognise that the amount of worry is disproportionate while still feeling unable to disengage from it. Diagnosis depends on the complete pattern rather than one symptom or a questionnaire score. The duration threshold The NICE assessment appendix, using the DSM framework, describes worry occurring on most days for at least six months. DSM diagnostic criteria also require excessive anxiety and worry more days than not during a six month period. ICD 11 describes persistent generalised anxiety over several months, with worry spreading across multiple everyday areas. A shorter period can still be clinically important, but it may be described as subthreshold while assessment and support continue. The central diagnostic features The first central feature is excessive anxiety and worry about several events or activities. The second is difficulty controlling the worry once it begins. The focus should not be confined to another disorder, such as panic attacks, social judgement, contamination or serious illness. The symptoms must cause meaningful distress or interfere with social, occupational or other important functioning. Worry across several life domains A person with GAD may worry simultaneously about work performance, family safety, finances, health and minor daily decisions. When one concern settles, attention often shifts quickly towards another possible problem. Ordinary uncertainty can be interpreted as requiring repeated prediction, checking or preparation. This broad distribution distinguishes GAD from disorders organised around one main fear. Difficulty controlling worry People with GAD often describe worry as automatic, repetitive and mentally exhausting. Attempts to suppress it can produce temporary relief followed by stronger attention to the feared possibility. Reassurance may help briefly, but uncertainty soon returns and another question arises. The problem is not simply choosing to think negatively or failing to relax properly. Physical and cognitive symptoms Persistent threat anticipation keeps several body and attention systems activated. The recognised associated cluster includes restlessness, fatigue, poor concentration, irritability, muscle tension and disturbed sleep. The DSM adult framework requires at least three of these six associated features alongside the central worry pattern. Other bodily sensations can occur, but they do not replace the requirement for pervasive uncontrollable worry. Restlessness Restlessness can feel like being keyed up, unable to settle or constantly prepared for something to go wrong. A person may pace, fidget, change tasks frequently or feel uncomfortable during quiet moments. Restlessness can also result from medicines, stimulant use, pain, attention disorders or mood elevation. The clinician therefore interprets it within the wider history rather than treating it as specific to GAD. Fatigue Chronic vigilance, muscle tension and disrupted sleep can leave a person persistently tired. They may feel exhausted despite having completed little physical activity. Fatigue can reduce exercise, social activity and confidence, which may then reinforce anxiety and low mood. Anaemia, thyroid disease, infection, sleep apnoea and other physical causes may also require consideration. Concentration difficulties Worry occupies working memory and repeatedly redirects attention towards possible threats. Reading, following conversations, making decisions and completing tasks can become difficult. People may interpret this as personal failure or fear that they are developing a neurological illness. Concentration can also be affected by depression, poor sleep, medicines, substance use and physical illness. Irritability Sustained tension can lower tolerance for noise, interruption, mistakes and ordinary uncertainty. A person may become impatient with family, colleagues or themselves and then feel guilty afterwards. Irritability can be prominent even when the person does not describe feeling frightened. It also occurs in depression, trauma related disorders, substance withdrawal and bipolar mood episodes. Muscle tension Muscle tension commonly affects the jaw, neck, shoulders, scalp or back. It can cause headaches, facial pain, teeth clenching and generalised aching. Some people notice abdominal tension, nausea or bowel disturbance during periods of worry. Persistent or focal pain still requires appropriate physical assessment rather than automatic attribution to anxiety. Sleep disturbance A person may struggle to fall asleep because worry becomes more prominent when distractions stop. They may wake repeatedly, dream vividly or feel unrefreshed after apparently adequate sleep. Trying to force sleep can increase monitoring and frustration, making the problem more persistent. Sleep treatment should address worry patterns, routines, substances and any separate sleep disorder. Other bodily symptoms GAD can accompany palpitations, sweating, trembling, dizziness, nausea, breathlessness and urinary or bowel urgency. These sensations arise through autonomic arousal and increased attention to bodily change. They are genuine physical experiences rather than imaginary symptoms. New, severe or atypical symptoms require medical assessment before anxiety is accepted as the explanation. Functional impairment GAD can impair work, education, relationships, parenting, self care and financial decision making. A person may spend hours checking, planning, seeking reassurance or preparing for unlikely outcomes. Avoidance can narrow travel, social activity, responsibility and independence. Someone may remain employed while using considerable energy to conceal severe internal distress. Normal everyday worry Normal worry is usually connected to a realistic problem and encourages proportionate action. It is often time limited, more controllable and less likely to disrupt several life domains. A person can usually redirect attention when the problem is addressed or temporarily set aside. Normal worry can still be painful, particularly during genuine uncertainty, without constituting GAD. GAD does not mean every concern is unrealistic People with GAD can face genuine financial, health, family or workplace problems. The disorder concerns the intensity, persistence and generalisation of worry rather than whether every topic is imaginary. Practical support may be as important as psychological treatment when real adversity is present. Care should never use the diagnosis to dismiss legitimate concerns or discrimination. The worry cycle A trigger creates uncertainty, which is interpreted as potentially dangerous or requiring immediate resolution. Worry then feels like preparation, responsibility or protection against being caught unaware. Short term reassurance, checking or avoidance reduces discomfort, reinforcing the same response next time. Treatment helps the person tolerate uncertainty and replace unhelpful safety behaviours with more flexible responses. Intolerance of uncertainty Intolerance of uncertainty means finding not knowing especially distressing or unacceptable. The person may believe that enough analysis can prevent mistakes, illness, rejection or loss. Because complete certainty is rarely available, thinking continues without producing a final answer. CBT can examine these beliefs without claiming that all uncertainty is harmless. Reassurance seeking Reassurance can involve repeatedly asking relatives, clinicians, colleagues or online sources whether something is safe. It provides short relief but can weaken confidence in making decisions without external confirmation. Family members may become drawn into repeated checking and discussion. A treatment plan can reduce reassurance gradually while preserving appropriate help seeking for genuine concerns. Avoidance Avoidance can include delaying decisions, refusing responsibility, avoiding news, travel or medical information, or delegating ordinary tasks. It prevents the person learning that uncertainty can be tolerated and that feared outcomes are often manageable. Avoidance can also protect someone from real danger, so its function must be understood before it is challenged. Therapeutic change is gradual and collaborative rather than forced exposure without consent. GAD and panic attacks A panic attack is a sudden surge of intense fear or discomfort reaching a peak within minutes. GAD produces more continuous apprehension and worry, although panic attacks can occur during GAD. Panic disorder centres on recurrent unexpected panic attacks and concern or behavioural change about further attacks. The disorders can coexist and may require a combined formulation. GAD and social anxiety disorder Social anxiety disorder centres on fear of scrutiny, embarrassment, rejection or negative evaluation in social situations. GAD worry spreads across several life areas and is not restricted to social judgement. A person can have both disorders, particularly when workplace or relationship worries become pervasive. Assessment identifies which pattern is primary and most impairing rather than assuming one label explains everything. GAD and health anxiety Health anxiety centres on persistent fear of having or developing a serious illness. The person may repeatedly check their body, seek tests or avoid medical information. GAD can include health worries, but significant worry also occurs across several other domains. New physical symptoms should still receive proportionate medical assessment before reassurance strategies are addressed. GAD and obsessive compulsive disorder OCD involves obsessions, which are intrusive unwanted thoughts, images or urges, and compulsions intended to reduce distress or prevent harm. GAD worries usually concern plausible future problems and feel like extended verbal thinking. OCD may involve contamination, checking, symmetry, taboo thoughts or responsibility rituals. The distinction matters because exposure and response prevention is a central OCD treatment. GAD and post traumatic stress disorder PTSD follows exposure to a traumatic event and includes re experiencing, avoidance and persistent threat responses. GAD does not require a traumatic event and its worries are distributed across ordinary future possibilities. Trauma can nevertheless increase vulnerability to GAD, and both conditions can coexist. Trauma history should be explored sensitively without requiring detailed disclosure before trust and safety are established. GAD and depression Depression is one of the most common conditions accompanying GAD. Shared features include fatigue, poor sleep, concentration difficulty and reduced functioning. Depression adds persistent low mood, anhedonia, hopelessness, guilt or suicidal thoughts. NICE advises treating the primary disorder first, meaning the more severe condition most likely to improve overall functioning. Why suicide assessment matters GAD alone does not usually create the same suicide risk as severe depression, but comorbidity changes the picture. Hopelessness, substance misuse, self neglect and previous self harm increase concern. Clinicians ask directly about suicidal thoughts, planning, intent and access to means when depression or significant risk is present. Direct questions do not create suicidal thoughts and can make urgent support possible. GAD and substance use Alcohol, cannabis, sedatives and other substances may be used to quiet worry temporarily. Repeated use can worsen sleep, mood, dependence and rebound anxiety. Cocaine, amphetamines and other stimulants can cause severe anxiety and dangerous cardiovascular symptoms. Harmful or dependent substance use may require treatment first because anxiety can improve during supported recovery. Caffeine and stimulants Caffeine increases alertness and can cause tremor, palpitations, restlessness and sleep difficulty. Coffee, tea, cola, energy drinks, pre workout products and some headache medicines contribute to total intake. Nicotine, decongestants and prescribed stimulants can also increase arousal. A gradual reduction may clarify their contribution while avoiding caffeine withdrawal headaches and fatigue. Alcohol withdrawal Alcohol withdrawal can cause anxiety, tremor, sweating, nausea, insomnia and a rapid pulse. Severe withdrawal can progress to seizures, hallucinations or delirium tremens. This is not GAD and can become life threatening. A dependent person should seek medically supported withdrawal rather than stopping suddenly without assessment. Benzodiazepine withdrawal Regular benzodiazepine use can produce physical dependence, tolerance and withdrawal. Abrupt reduction may cause rebound anxiety, insomnia, tremor, sensory disturbance, confusion or seizures. Withdrawal symptoms can be mistaken for worsening GAD and lead to repeated dose escalation. Long term treatment should be reviewed and reduced through an individualised supervised taper when appropriate. Hyperthyroidism An overactive thyroid can cause anxiety, irritability, tremor, sweating, weight loss, heat intolerance and palpitations. Clues include persistent rapid pulse, neck swelling, diarrhoea or eye changes. A thyroid blood test is appropriate when the history or examination suggests this possibility. Hyperthyroidism and GAD can coexist, so identifying one does not automatically exclude the other. Arrhythmias and cardiac symptoms Heart rhythm disorders can cause sudden or sustained palpitations, dizziness, chest discomfort and breathlessness. A pulse examination and ECG may be needed when symptoms are new, irregular, exertional or associated with fainting. Anxiety can also make normal heartbeat variation more noticeable. Chest pain, collapse or severe breathlessness requires urgent medical assessment rather than reassurance alone. Other physical mimics Anaemia, hypoglycaemia, asthma, vestibular disorders, pain and medication effects can resemble parts of anxiety. Menopause related symptoms, pregnancy and endocrine changes can alter sleep, heart rate and emotional regulation. Physical assessment is targeted to the symptoms and risk rather than using an identical test panel for everyone. Normal investigations do not make symptoms unreal and should lead to a clear ongoing care plan. Medicine related anxiety Corticosteroids, thyroid hormone excess, bronchodilators, stimulants and some decongestants can increase anxiety symptoms. Antidepressants can temporarily increase agitation or anxiety when first started. A medicine timeline helps identify whether symptoms began after initiation, dose increase or withdrawal. Do not stop essential medication abruptly without advice because withdrawal or disease relapse can be dangerous. How GAD develops GAD develops through interacting biological, psychological and social influences. Inherited vulnerability, temperament, early adversity and learned patterns around uncertainty can contribute. Chronic illness, pain, financial strain, discrimination and caregiving demands can maintain worry. There is no single chemical imbalance or personality weakness that explains every case. Risk factors Risk is higher after previous anxiety or depression and when close relatives have similar conditions. Trauma, domestic abuse, bullying, chronic pain and persistent social adversity can increase vulnerability. Substance misuse and some medical conditions can worsen the course. Risk factors change probability but do not make GAD inevitable. Diagnosis is clinical There is no blood test, scan or physiological measurement that confirms GAD. Diagnosis uses the history of worry, associated symptoms, duration, distress and functional impairment. The clinician also considers other mental disorders, substances, medicines and physical conditions. A diagnosis should explain the pattern while leaving room to investigate new symptoms appropriately. GAD 2 and GAD 7 questionnaires The GAD 2 contains two brief questions about nervousness and difficulty controlling worry. A higher score suggests that fuller assessment may be useful. The GAD 7 explores seven symptoms and can help monitor change during treatment. Neither questionnaire diagnoses GAD or determines crisis risk without clinical assessment. The clinical interview The clinician asks which subjects provoke worry, how often it occurs and whether it can be controlled. They explore sleep, tension, restlessness, fatigue, concentration and irritability. The assessment includes functioning, avoidance, reassurance, physical symptoms and previous treatment. Depression, suicide risk, trauma, substance use, mania and safeguarding are also considered where relevant. Examination and investigations Physical observations and examination are guided by the presenting symptoms. Pulse, blood pressure, thyroid examination, cardiovascular assessment or neurological examination may be appropriate. Tests can include an ECG, thyroid function, full blood count or other targeted investigations. Urgent medical symptoms are assessed first rather than waiting for a routine mental health appointment. The NICE stepped care model NICE organises GAD treatment into four steps according to persistence, impairment, risk and previous response. The model begins with the least intrusive effective intervention while allowing faster escalation when impairment is marked. It does not require someone to fail every lower step before receiving necessary care. Treatment choice is collaborative and considers access, preference, comorbidity and previous experience. Step 1: identification and education Step 1 includes recognition, comprehensive assessment and clear explanation of GAD. The clinician discusses the nature of persistent worry and available treatment options. Symptoms and functioning are monitored actively rather than leaving the person without follow up. Education and active monitoring can be sufficient for less severe or shorter duration presentations. Active monitoring Active monitoring means agreeing when and how symptoms and functioning will be reviewed. The person receives information about worsening symptoms and routes to seek earlier help. Practical contributors such as caffeine, alcohol, sleep disruption and current stressors can be addressed. It is not appropriate as the only response to marked impairment, self neglect or significant suicide risk. Step 2: low intensity psychological interventions When diagnosed GAD has not improved after Step 1, NICE recommends a low intensity psychological intervention guided by preference. Options include individual non facilitated self help, guided self help and psychoeducational groups. The materials should be based on CBT principles rather than generic motivational advice. Progress and functioning are reviewed so that ineffective treatment is not continued indefinitely. Non facilitated self help Non facilitated self help uses structured written, audio or digital CBT based material. NICE describes systematic use over at least six weeks with only minimal practitioner contact. The person practises skills rather than reading information passively. Alternative formats or communication support should be offered when reading, language or disability creates barriers. Guided self help Guided self help uses structured CBT based material with support from a trained practitioner. The practitioner helps select exercises, review progress and resolve practical barriers. NICE describes five to seven weekly or fortnightly sessions, usually lasting twenty to thirty minutes. It is a recognised treatment and should not be presented as being left to manage alone. Psychoeducational groups Psychoeducational groups teach anxiety and CBT principles in an interactive format. Participants learn through structured material, discussion and observing how others practise skills. Groups can reduce isolation and normalise common anxiety processes. They should be delivered by trained practitioners and adapted for accessibility and cultural context. Step 3: marked impairment or inadequate response Step 3 applies when functioning is markedly impaired or Step 2 has not produced an adequate response. NICE recommends offering either high intensity psychological treatment or drug treatment. Neither route is considered universally superior, so preference and clinical circumstances guide the choice. People should receive balanced information about benefits, adverse effects and withdrawal risks. High intensity CBT CBT for GAD examines worry beliefs, intolerance of uncertainty, avoidance and reassurance behaviours. Treatment can include worry awareness, cognitive work, behavioural experiments, problem solving and planned exposure to uncertainty. NICE describes approximately twelve to fifteen weekly sessions with a trained and supervised therapist. The goal is flexible coping rather than eliminating every anxious thought. Applied relaxation Applied relaxation teaches recognition of early tension and rapid use of relaxation skills in anxiety provoking situations. Training progresses from deliberate muscle relaxation towards applying the skill during everyday triggers. NICE considers it an evidence based high intensity alternative to CBT for GAD. It is more than occasional breathing exercises and usually requires structured therapist led practice. Choosing psychological treatment Choice depends on preference, availability, communication needs and previous experience. Some people prefer a therapy that directly examines worry, while others prefer applied relaxation skills. Therapy should be delivered by trained practitioners using an evidence based protocol. A poor therapeutic match can be reviewed without concluding that psychological treatment as a whole cannot help. Drug treatment at Step 3 If medication is chosen, NICE recommends offering a selective serotonin reuptake inhibitor, called an SSRI. NICE advises considering sertraline first because of cost effectiveness, noting that use for GAD may be off label. An alternative SSRI or a serotonin noradrenaline reuptake inhibitor can be offered when the first medicine is ineffective. Selection considers previous response, interactions, withdrawal profile, overdose toxicity and personal preference. SSRIs are not only depression medicines SSRIs are called antidepressants because they were developed and widely used for depression. They also have evidence for GAD and several other anxiety disorders. Using an SSRI does not mean that the clinician believes the person necessarily has depression. The medicine gradually modifies signalling within networks involved in threat, learning and emotional regulation. Realistic expectations when starting medication An SSRI or SNRI does not provide immediate relief like a sedative. Some benefit develops gradually over one week or more, with fuller improvement often taking several weeks. Early nausea, sleep change, agitation or temporarily increased anxiety can occur before improvement. A clear review plan helps manage adverse effects without abandoning treatment automatically or escalating unsafely. Early activation and suicide monitoring SSRIs and SNRIs can initially increase anxiety, agitation and sleep difficulty. NICE advises additional suicide and self harm monitoring for people younger than thirty receiving these medicines. They should usually be reviewed within one week and monitored weekly during the first month. Any age requires prompt review when suicidal thinking, severe agitation or unusual behavioural change emerges. Medication review NICE recommends reviewing effectiveness and adverse effects every two to four weeks during the first three months. Reviews can become approximately three monthly after the initial period when treatment remains stable. The clinician checks adherence, benefit, activation, sleep, sexual effects and withdrawal after missed doses. Treatment is changed through shared decision making rather than dose escalation without reassessment. How long medication continues When medication is effective, NICE advises continuing it for at least one year because relapse risk is high. This period includes time after meaningful improvement, not only the weeks required to start responding. Recurrent illness and residual symptoms can justify longer treatment. The decision is reviewed periodically rather than assuming every person needs indefinite medication. Antidepressant withdrawal SSRIs and SNRIs can produce withdrawal symptoms after sudden stopping, missed doses or rapid reduction. Symptoms can include dizziness, nausea, electric shock sensations, agitation, sleep disturbance and anxiety. Withdrawal does not mean that the medicine is addictive in the usual sense of craving and intoxication. A gradual personalised taper reduces risk and should be planned with the prescriber. SNRIs SNRIs affect serotonin and noradrenaline signalling and can treat GAD. Venlafaxine has a recognised withdrawal burden and greater toxicity in overdose than many SSRIs. Some SNRIs can increase blood pressure or cause nausea, sweating and sexual adverse effects. Medicine choice therefore considers physical health, suicide risk and previous withdrawal experience. Pregabalin NICE recommends considering pregabalin when SSRIs and SNRIs cannot be tolerated. Pregabalin is a controlled medicine with recognised risks of dependence, misuse and withdrawal. It can cause dizziness, sleepiness, blurred vision, swelling and weight gain. Pregnancy potential, substance use history and a plan for eventual reduction require discussion before prescribing. Benzodiazepines Benzodiazepines enhance inhibitory signalling and can reduce anxiety rapidly. NICE advises against using them for GAD except as a short term measure during crises. They do not provide the learning and long term adaptation produced by psychological therapy or sustained first line medication. Routine long term prescribing can create more harm than benefit. Why long term benzodiazepines are discouraged Regular use can produce tolerance, physical dependence, withdrawal and sometimes addiction. Sedation, slowed reaction time, impaired memory and falls can occur, particularly in older adults. Combining benzodiazepines with alcohol, opioids or other sedatives can suppress breathing and cause death. The MHRA strengthened UK warnings about addiction, dependence, withdrawal and tolerance in 2026. Stopping benzodiazepines safely A person taking benzodiazepines regularly should not stop suddenly without advice. The dose is usually reduced gradually through an individualised plan, especially after prolonged use. Severe withdrawal can cause confusion, hallucinations or seizures and requires urgent medical care. A supported taper should include treatment for the underlying anxiety rather than removing medication without replacement care. Medicines not routinely offered NICE advises against antipsychotic treatment for GAD within primary care. Sedating medicines can reduce arousal without treating the central persistent worry pattern. Over the counter remedies and herbal products can interact with prescribed medicines and may lack reliable safety evidence. Every product should be discussed with a pharmacist or prescriber, including supplements bought online. When one treatment is not enough If a full high intensity psychological treatment does not help, NICE recommends offering medication. If medication does not help, another medicine or a high intensity psychological intervention can be offered. A partial medication response can be supplemented with high intensity psychological treatment. The diagnosis, adherence, dose, duration, comorbidity and continuing adversity are reviewed before labelling treatment ineffective. Step 4: specialist care Step 4 is for complex treatment refractory GAD with very marked impairment or high risk. Referral is considered when severe anxiety occurs with self harm risk, self neglect, major comorbidity or inadequate Step 3 response. A specialist team reviews previous psychological and medication treatment, adherence, home circumstances and support. Complex combinations or augmentation should be managed only by practitioners with appropriate expertise. Supporting daily functioning Recovery involves more than lowering a symptom score. Treatment may include graded return to work, education support, debt advice or help with caring responsibilities. Regular movement, meals and sleep routines can support nervous system regulation and physical health. These measures complement evidence based treatment and should not be presented as a cure through willpower. Exercise Physical activity can reduce tension, improve sleep and support mood for some people. The activity should be realistic, safe and adapted for pain, disability and current fitness. Avoiding all exercise because of harmless increases in heart rate can reinforce fear of bodily sensations. Exertional chest pain, fainting or unexplained severe breathlessness requires medical assessment before reassurance. Sleep and worry management A consistent sleep opportunity and reduced late caffeine can improve treatment conditions. Long periods awake in bed can strengthen the association between bed and worry. A therapist may use structured strategies addressing pre sleep rumination and unhelpful safety behaviours. Persistent snoring, breathing pauses or severe daytime sleepiness can indicate a separate sleep disorder. Problem solving and hypothetical worry Practical worry concerns a problem that can be addressed through a specific action. Hypothetical worry consists mainly of repeated questions beginning with what if. Problem solving skills help identify the next practical step without demanding certainty about every outcome. CBT also teaches how to disengage when further analysis is no longer useful. Family and carers Family members can support appointments, practise agreed strategies and recognise deterioration. They can also become exhausted through repeated reassurance or taking over feared tasks. Therapy may include guidance on supporting recovery without reinforcing avoidance. Information is shared with consent unless serious immediate risk requires protective action. Pregnancy and breastfeeding Anxiety can occur or worsen during pregnancy and after childbirth. Psychological treatment is often attractive because it avoids medicine exposure, but significant illness should not be undertreated. Medication decisions compare the risks of untreated GAD with the specific medicine's reproductive and neonatal evidence. Pregabalin, benzodiazepines and antidepressants each require individual specialist informed review rather than abrupt stopping. Older adults GAD in older adults may present through insomnia, pain, palpitations, repeated reassurance seeking or concern about physical illness. Medication review is important because adverse effects, falls and interactions can increase with age and frailty. Hearing, vision and cognitive needs may require adapted psychological treatment. Anxiety is not an inevitable consequence of ageing and remains treatable. Safeguarding and adversity Persistent anxiety may occur within domestic abuse, coercive control, exploitation or unsafe housing. The person's fear may be proportionate to genuine danger rather than solely generated by GAD. Assessment must create opportunities for private disclosure and appropriate safeguarding support. Psychological treatment should not be used to help someone tolerate an unsafe situation without practical protection. When urgent mental health help is needed Severe functional collapse, self neglect or inability to care safely for dependants requires urgent assessment. Comorbid depression with suicidal planning or intent requires same day crisis care. Psychosis, mania or catatonia suggests another severe disorder requiring urgent specialist assessment. Emergency services are needed when there is immediate danger, a serious act or urgent medical instability. Safety planning A safety plan identifies warning signs, coping actions, supportive contacts and urgent services. It includes reducing access to means when suicide risk is present. The plan is collaborative, accessible and updated when circumstances change. A safety plan supports care but does not replace same day assessment when intent or immediate danger is present. Recovery and relapse prevention Recovery can involve reduced worry, improved tolerance of uncertainty and restored participation in daily life. Symptoms may fluctuate without meaning that all treatment benefit has been lost. A relapse plan records early warning signs, effective skills and routes back to support. Medication is reduced gradually, while psychological skills continue after formal sessions end. The central safety message GAD is persistent, pervasive and difficult to control worry causing physical symptoms and functional impairment over many months. Diagnosis requires differentiation from other anxiety disorders, depression, substances, medicines and physical illness. NICE treatment progresses from education and low intensity CBT based support to high intensity therapy or medication, with specialist escalation when necessary. Suicidal depression, severe self neglect, dangerous withdrawal and acute cardiac or endocrine symptoms require urgent assessment.

Generalised anxiety disorder is defined by persistent, excessive and difficult to control worry across several life areas, not by occasional anxiety alone. Effective care combines careful medical and psychiatric assessment with stepped psychological or medication treatment matched to impairment, preference and risk.